Triangel Better Healthcare Solution Launches ENDO PRO Dual-Technology Platform Globally, Ushering in a New Era of “Single Anesthesia, Dual Treatment” in Aesthetic Medicine
As the global aesthetic medicine market increasingly demands minimally invasive, highly effective, and low-downtime treatment options, Triangel Better Healthcare Solution today officially launched its groundbreaking dual-technology platform, ENDO PRO, to the global market. This system sets a new benchmark for efficacy in facial contouring and skin regeneration through its unique combination of “980nm + 1470nm dual-wavelength laser” and “fractional radiofrequency microneedling” technologies.
1.Technological Innovation: Dual Effects in a Single Treatment
ENDO PRO’s core competitiveness lies in its unique synergistic mechanism. The platform integrates two advanced technologies: First, through the 980nm and 1470nm dual-wavelength endolaser, it precisely targets the subcutaneous tissue layer. The 980nm wavelength effectively promotes fat dissolution, while the 1470nm wavelength strongly stimulates the generation of new collagen, achieving the goal of tightening connective tissue and improving skin structure. On the other hand, fractional RF microneedling technology creates microchannels in the skin using ultra-fine sterile needles, simultaneously releasing controlled radiofrequency heat energy to activate the skin’s natural repair mechanisms, significantly shrinking pores, reducing sebum secretion, and improving inflammatory acne and acne scars. This platform supports “single anesthesia, one procedure, dual treatment,” and clinical data shows that its visible improvement speed is up to 30% faster compared to traditional methods.
2.Clinical Validation: Data-Driven Superior Efficacy
ENDO PRO’s clinical efficacy has been internationally recognized. In 2024, a clinical trial involving 37 patients, led by Dr. Layla Dias, Florida’s first ENDO LASER trainer, used a combination of ENDO PRO treatments for facial contouring and skin regeneration. The clinical results fully demonstrated the platform’s significant effects in improving facial contours, reducing wrinkles, and enhancing skin texture.
“The launch of ENDO PRO represents our deep commitment to the principle of ‘equal emphasis on effectiveness and safety’ in medical aesthetics. We believe that with its powerful dual-technology platform and clinically proven efficacy, ENDO PRO will become a key partner for global medical aesthetics practitioners to achieve breakthroughs in treatment and enhance commercial value.”
Post time: Jun-24-2026